POSTER SESSION VI
Wednesday, March 28, 2007   —  1:00 PM - 4:00 PM
Exhibit Hall B - 1


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
155 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with t(2;14)(p13;q32) Is Associated with Atypical Morphology, Unmutated IgVH Genes, and an Aggressive Clinical Course (1216)
CC Yin, LJ Medeiros, LL Barron, LV Abruzzo - UT MD Anderson Cancer Center, Houston, TX
Add
156 Flow Cytometric Identification of CD5-Negative Chronic Lymphocytic Leukemia (1157)
ME Miller, S Hill, JH Greenwood, SN Preobrazhenshy, Z Chen, DW Bahler - University of Utah Health Sciences Center, Salt Lake City, UT; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT
Add
157 Expression of Cyclins D1, D2, and D3 in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (1084)
W Chen, GZ Rassidakis, V Leventaki, LV Abruzzo, CE Bueso-Ramos, RW McKenna, LJ Medeiros - UT Southwestern Medical Center at Dallas, Dallas; UT MD Anderson Cancer Center, Houston
Add
158 MYC Gene Translocation in Chronic Lymphocytic Leukemia (1121)
YO Huh, F Vega, E Schlette, LJ Medeiros, LV Abruzzo - University of Texas M. D. Anderson Cancer Center, Houston, TX
Add
159 Monitoring of the Graft vs Leukemia Effect in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma after Allogeneic Hematopoietic Stem Cell Transplant (1128)
TV Isaacson, OI Krijanovski, WG Finn - University of Michigan, Ann Arbor, MI
Add
160 ZAP70 Expression Determined by Immunohistochemistry of Cell Clots Correlates with IgH Mutation Status and Cytogenetics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (1069)
I Bansal, E Hyjek, W Tam, A Chiu, R Furman, M Coleman, S Ely, E Fusco, S Mathew, DM Knowles, A Chadburn - Weill Cornell Medical College, NY, NY
Add
161 Correlation of ZAP-70, CD38 and Prognostic FISH Studies in CLL/SLL (1083)
S Chen, H Vall, T Ha, A Hi, KJ Bloom - CLARiENT, Aliso Viejo, CA
Add
162 High Affinity IL-2 Receptor (CD25) Expression among Chronic Lymphocytic Leukemia Patients Is Independent of Mutational Status and ZAP-70 Positivity (1118)
JM Howell, J Luider, H Wong, M Perrizolo, D Demetrick, I Auer, A Mansoor - University of Calgary/Calgary Laboratory Services (CLS), Calgary, AB, Canada
Add
163 Somatic Hypermutation Status in CLL Correlates with Patterns of Genotypic Aberrations: Results of a Large Single Institution Data Set (1113)
C Hannah, L Abruzzo, JL Jorgensen, N Reeves, R Luthra, D Jones - MD Anderson Cancer Center, Houston, TX
Add
164 Chronic Lymphocytic Leukemia with Dual Surface Immunoglobulin Light Chain Expression (1213)
H Xu, S Yang, X Zhong, D Xu - Boston University School of Medicine, Boston, MA
Add
165 Activation of p70S6 Kinase Is Independently Associated with a Poorer Prognosis in Patients with Mantle Cell Lymphoma Treated with H-CVAD+R (1126)
KV Inamdar, RJ Knoblock, JE Romaguera, E Drakos, LJ Medeiros, GZ Rassidakis - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
166 Correlation of ATM Protein Expression with ATM Mutation Status and Overall Survival in Mantle Cell Lymphoma (1223)
MI Zulfiqar, JG Hacia, WC Chan, DD Weisenburger, TC Greiner - University of Nebraska Medical Center, Omaha, NE; University of Southern California, Los Angeles, CA
Add
167 Expression of eIF4E Predicts Clinical Outcome in Patients with Mantle Cell Lymphoma Treated with H-CVAD+R Regimen (1124)
KV Inamdar, JE Romaguera, RJ Knoblock, E Drakos, LJ Medeiros, GZ Rassidakis - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
168 Flow Cytometry Evaluation of Peripheral Blood Lymphocytosis in Differentiating Mature B-Cell Neoplasms Benefits from Routine T(11;14) Studies (1136)
BH Kim, R Linfesty, RW Sharpe, KJ Bethel - Scripps Clinic, La Jolla, CA
Add
169 Intrasinusoidal Infiltration Is More Frequent in Splenic Marginal Zone Lymphoma, but Lymphoid Follicle Formation Is Common in All Types of Marginal Zone Lymphomas (1066)
HM Amin, KV Inamdar, LJ Medeiros, EJ Schlette - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
170 Different Chemokine Receptor Expression Profile in Extragastric and Gastric MALT-Lymphomas (1062)
A Aigelsreiter, AJA Deutsch, E Stelzl, C Beham-Schmid, A Beham, W Linkesch, H Schaider, HH Kessler, P Neumeister - MUG, Graz, Austria
Add
171 Follicular Immunoarchitecture of Marginal Zone B-Cell Lymphoma and It’s Usefulness in Diagnosis (1115)
S Hao, JPS Yang, S Wang, K Dresser, B Woda - University of Massachusetts Medical School, Worcester, MA; Fallon Clinic, Worcester, MA
Add
172 Genome-Wide Array Based Comparative Genomic Hybridization of Ocular Marginal Zone B Cell Lymphoma: Comparison with Pulmonary and Nodal Marginal Zone B Cell Lymphoma (1145)
DK Lee, WS Kim, S Karnan, H Tagawa, YD Kim, M Seto, YH Ko - Samsung Medical Center, Sungkyunkwan University, Seoul, Korea; Aichi Cancer Center Research Institute, Nagoya, Japan
Add
173 Morphologic and Immunophenotypic Findings in Extranodal Marginal Zone B-Cell Lymphoma of the Ocular Adnexa: Analysis of 34 Cases (1186)
A Ruiz, SH Swerdlow, JR Cook - Cleveland Clinic, Cleveland, OH; University of Pittsburgh School of Medicine, Pittsburgh, PA
Add
174 Array-Based Comparative Genomic Hybridization of Ocular Adnexa MALT Lymphoma (1089)
JR Cook, D Gaile, N Nowak, J Conroy, SH Swerdlow, R Tubbs - Cleveland Clinic, Cleveland, OH; Roswell Park Cancer Institute, Buffalo, NY; University of Pittsburgh School of Medicine, Pittsburgh, PA
Add
175 p-JAK2, p-STAT6, and HGAL Expression in Diagnostic Biopsies of Primary Mediastinal Large B-Cell Lymphoma Support the Presence of an Active Interleukin-4 Signaling Pathway (1209)
NT Wongchaowart, B Pohlman, J Bena, Y Natkunam, I Lossos, ED Hsi - The Cleveland Clinic, Cleveland, OH; The Cleveland Clinic, Cleveland; Stanford University School of Medicine, Stanford, CA; University of Miami, Miami, FL
Add
176 MicroRNA-Mediated Translation Repression of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B-Cell Lymphomas (1162)
K Nie, HT Allawi, V Lyamichev, MF Gomez, YF Liu, A Chadburn, DM Knowles, W Tam - Weill Cornell Medical College, New York, NY; Third Wave Technologies, Madison, WI
Add
177 Correlation of D-Type Cyclin Expression with Immunophenotype in Diffuse Large B-Cell Lymphomas (1067)
SR Backus, S Chickkamuniyappa, YH Diep, RS Robetorye - The University of Texas Health Science Center at San Antonio, San Antonio, TX
Add
178 Comparative Study for Expression and Prognostic Value of Differentiation Markers between Nodal and Extranodal Diffuse Large B Cell Lymphomas (1144)
DK Lee, YJ Kim, S Park, KH Kim, WS Kim, YH Ko - Samsung Medical Center, Sungkyunkwan University, Seoul, Korea; Seoul Veterans Hospital, Seoul, Korea
Add
179 A Mouse Model of Non-Hodgkin’s Lymphoma of the Diffuse Large B Cell Type: Evaluation of New Chemotherapeutic Regimens and Their Effects (1212)
H Xu, D Xu, T Goncalves, H Longe, GV Denis - Boston University School of Medicine, Boston, MA
Add
180 Histopathologic Evaluation of a Mouse Model of Non-Hodgkin’s Lymphoma of Diffuse Large B Cell Type (1211)
D Xu, H Xu, T Goncalves, H Longe, GV Denis - Boston University School of Medicine, Boston, MA
Add
181 The Detection of TCL-1 and CD38 Facilitates the Distinction of Burkitt Lymphoma from Diffuse Large B-Cell Lymphoma (1184)
SJ Rodig, A Shahsafaei, DM Dorfman - Brigham & Women’s Hospital, Boston, MA
Add
182 Burkitt Lymphoma and Ki67 Measured Proliferation Index: Their Clinical Manifestations and Common Immunohistochemical Features (1185)
K Ru, J Choi, M Paessler - Children’s Hospital of Philadelphia, Philadelphia, PA; Hospital of University of Pennsylvania, Philadelphia, PA
Add
183 Multiple Myeloma 1 Expression in Burkitt Lymphoma Is More Frequent in Cases with Complex Karyotypes and Correlates Inversely with Epstein-Barr Virus Infection (1109)
R Gupta, D Baiyee, S Alexander, VV Murty, S Subramaniyam, B Alobeid, G Bhagat - Columbia University Medical Center, New York, NY
Add
184 Fluorine-18 Fluoro-Deoxyglucose Positron Emission Tomography Scan Correlates with Histologic Grade in Follicular Lymphoma (1161)
T Nazeer, I Ahmad, RA Patel, A Hayner-Buchan, CE Sheehan, G Wilner, L Novak, J Cyriac, M Karam - Albany Medical College, Albany, NY
Add
185 CXCR4 Expression in Follicular Lymphomas (1064)
MS Almiski, N Razumilava, M Kurrer, E Levi - Wayne State University, Detroit, MI; University Hospital, Zurich, Switzerland; John D. Dingell VA Medical Center, Detroit, MI
Add
186 Macrophages and Regulatory T Cells in Follicular Lymphoma: A Tissue Microarray Study on 181 Patients (1204)
S Waelti, D Korol, E Levi, C Renner, N Probst-Hensch, H Moch, M Kurrer - University Hospital, Zurich, Switzerland; John D. Dingell VAMC and Wayne State University, Detroit, MI
Add
187 Cytogenetic Characterization of t(14;18)-Negative Non-Cutaneous Follicular Lymphoma (1099)
K Fu, J Iqbal, HM Geng, F d’Amore, E Chan, XL Shi, S Jain, BJ Dave, WC Chan - University of Nebraska Medical Center, Omaha, NE; Århus University Hospital, Århus, Denmark
Add